These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1071668)

  • 41. Hemodynamic effects of verapamil in essential hypertension at rest and during exercise.
    Lund-Johansen P
    Acta Med Scand Suppl; 1984; 681():109-15. PubMed ID: 6587749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of nicotinic acid on myocardial metabolism in man at rest and during exercise.
    Lassers BW; Wahlqvist ML; Kaijser L; Carlson LA
    J Appl Physiol; 1972 Jul; 33(1):72-80. PubMed ID: 5037413
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of respiratory acidosis on metabolism in exercise.
    Ehrsam RE; Heigenhauser GJ; Jones NL
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Jul; 53(1):63-9. PubMed ID: 6811526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
    Lund-Johansen P; Omvik P
    Eur Heart J; 1992 Feb; 13(2):281-6. PubMed ID: 1555629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic effects in muscle during antihypertensive therapy with beta 1- and beta 1/beta 2-adrenoceptor blockers.
    Frisk-Holmberg M; Jorfeldt L; Juhlin-Dannfelt A
    Clin Pharmacol Ther; 1981 Nov; 30(5):611-8. PubMed ID: 6117392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
    Ades PA; Wolfel EE; Hiatt WR; Fee C; Rolfs R; Brammell HL; Horwitz LD
    Eur J Clin Pharmacol; 1989; 36(1):5-10. PubMed ID: 2917588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients.
    Seideman P; Grahnén A; Haglund K; Lindström B; Von Bahr C
    Br J Clin Pharmacol; 1982 Jun; 13(6):865-70. PubMed ID: 7093116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic effects of atenolol and doxazosin in healthy volunteers during prolonged physical exercise.
    Cosenzi A; Sacerdote A; Bocin E; Molino R; Mangiarotti M; Bellini G
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):142-6. PubMed ID: 7723344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fat metabolism in heavy exercise.
    Jones NL; Heigenhauser GJ; Kuksis A; Matsos CG; Sutton JR; Toews CJ
    Clin Sci (Lond); 1980 Dec; 59(6):469-78. PubMed ID: 6777109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of diphenylhydantoin on metabolic and growth hormone changes during and after exercise.
    Chalmers RJ; Johnson RH
    J Neurol Neurosurg Psychiatry; 1983 Jul; 46(7):662-5. PubMed ID: 6886706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemodynamics and leg muscle metabolism at rest and during exercise in young healthy men after prenalterol.
    Dahlström U; Atterhög JH; Jorfeldt L
    Clin Pharmacol Ther; 1983 Jun; 33(6):701-9. PubMed ID: 6851402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The metabolic response to exercise in chronic alcoholics.
    Chalmers RJ; Sulaiman WR; Johnson RH
    Q J Exp Physiol Cogn Med Sci; 1977 Jul; 62(3):265-74. PubMed ID: 588023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Varying cardiac and metabolic effects of isoproterenol relative to the condition of physical training].
    Lehmann M; Dickhuth HH; Stamer S; Spielberger B; Keul J
    Klin Wochenschr; 1983 Jun; 61(11):567-75. PubMed ID: 6876686
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of prolonged beta-blockade on energy metabolism and adrenergic responses in the rat.
    Harri MN
    Med Biol; 1977 Oct; 55(5):268-76. PubMed ID: 592903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Submaximal endurance exercise performance during enalapril treatment in patients with essential hypertension.
    van Baak MA; Mooij JM; Wijnen JA; Tan FS
    Clin Pharmacol Ther; 1991 Aug; 50(2):221-7. PubMed ID: 1651201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
    Lund-Johansen P
    Eur Heart J; 1983 Jul; 4 Suppl D():1-12. PubMed ID: 6137366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients.
    Castenfors J; Johnsson H; Orö L
    Acta Med Scand; 1973 Mar; 193(3):189-95. PubMed ID: 4571479
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of a meal on cardiopulmonary and metabolic changes during exercise.
    Jones NL; Haddon RW
    Can J Physiol Pharmacol; 1973 Jun; 51(6):445-50. PubMed ID: 4727812
    [No Abstract]   [Full Text] [Related]  

  • 60. Utilization of blood-borne and intramuscular substrates during continuous and intermittent exercise in man.
    Essén B; Hagenfeldt L; Kaijser L
    J Physiol; 1977 Feb; 265(2):489-506. PubMed ID: 850204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.